Belimumab, an anti-BLyS human monoclonal antibody for potential treatment of inflammatory autoimmune diseases

Changhai Ding

Research output: Contribution to journal › Article › Research › peer-review

Original language	English
Pages (from-to)	1805 - 1814
Number of pages	10
Journal	Expert Opinion on Biological Therapy
Volume	8
Issue number	11
DOIs	https://doi.org/10.1517/14712598.8.11.1805
Publication status	Published - 2008
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

@article{9917221a7016477b89d30d17588820cf,

title = "Belimumab, an anti-BLyS human monoclonal antibody for potential treatment of inflammatory autoimmune diseases",

author = "Changhai Ding",

year = "2008",

doi = "10.1517/14712598.8.11.1805",

language = "English",

volume = "8",

pages = "1805 -- 1814",

journal = "Expert Opinion on Biological Therapy",

issn = "1471-2598",

publisher = "Taylor \& Francis",

number = "11",

}

TY - JOUR

T1 - Belimumab, an anti-BLyS human monoclonal antibody for potential treatment of inflammatory autoimmune diseases

AU - Ding, Changhai

PY - 2008

Y1 - 2008

UR - http://informahealthcare.com/doi/pdf/10.1517/14712598.8.11.1805

UR - https://www.scopus.com/pages/publications/56249101045

U2 - 10.1517/14712598.8.11.1805

DO - 10.1517/14712598.8.11.1805

M3 - Article

SN - 1471-2598

VL - 8

SP - 1805

EP - 1814

JO - Expert Opinion on Biological Therapy

JF - Expert Opinion on Biological Therapy

IS - 11

ER -